Patents by Inventor Nicolas Chamberlain

Nicolas Chamberlain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240216365
    Abstract: Compositions and methods involving protein disulfide isomerase (PDI) inhibitors, such as protein disulfide isomerase A3 (PDIA3) inhibitory compounds, for human coronavirus, such as severe acute respiratory syndrome (SARS) virus (e.g., SARS-CoV-2), therapies are disclosed herein.
    Type: Application
    Filed: December 15, 2023
    Publication date: July 4, 2024
    Applicant: The University of Vermont and State Agricultural College
    Inventors: Vikas Anathy, Nicolas Chamberlain, Amit Kumar
  • Patent number: 11883395
    Abstract: Compositions and methods involving protein disulfide isomerase (PDI) inhibitors, such as protein disulfide isomerase A3 (PDIA3) inhibitory compounds, for human coronavirus, such as severe acute respiratory syndrome (SARS) virus (e.g., SARS-CoV-2), therapies are disclosed herein.
    Type: Grant
    Filed: May 13, 2021
    Date of Patent: January 30, 2024
    Assignee: The University of Vermont and State Agricultural College
    Inventors: Vikas Anathy, Nicolas Chamberlain, Amit Kumar
  • Publication number: 20210353620
    Abstract: Compositions and methods involving protein disulfide isomerase (PDI) inhibitors, such as protein disulfide isomerase A3 (PDIA3) inhibitory compounds, for human coronavirus, such as severe acute respiratory syndrome (SARS) virus (e.g., SARS-CoV-2), therapies are disclosed herein.
    Type: Application
    Filed: May 13, 2021
    Publication date: November 18, 2021
    Inventors: Vikas Anathy, Nicolas Chamberlain, Amit Kumar